Wroclaw Medical University   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Wroclaw Poland (1950)

Organization Overview

First Clinical Trial
2002
NCT01084720
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Akademicka Poliklinika Stomatologiczna | DENTAL CLINIC ZAGREB | Departament of Family Medicine at Wroclaw Medical University | Department of Periodontology, Wroclaw Medical University | DEPT. OF DERMATOLOGY, UNIVERSITY OF MEDICINE, UL. CHALUBINSKIEGO, POLAND | Division of Sports Medicine/ Wroclaw Medical University | Medical University of Wroclaw (Co-Sponsor Poland) | Medical University Wrocław | Provincial Specialist Hospital in Wroclaw | Provincial Specialist Hospital in Wroclaw, Department of Urology | School of Dental Medicine | University Hospital No 1 Wroclaw | wroclaw medical univeristy | Wroclaw Medical University | Wroclaw Medical University, Poland

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 4)

Cardiovascular Diseases (Phase 3)

Chronic Periodontitis (Phase 4)

Colonic Neoplasms (Phase 4)

Conjunctivitis (Phase 3)

Conjunctivitis, Bacterial (Phase 3)

Diarrhea (Phase 2)

Elbow Tendinopathy (Phase 4)

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 4)

Glucose Intolerance (Phase 4)

Hypertrophy (Phase 2)

Hypertrophy, Left Ventricular (Phase 2)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 4)

Periodontitis (Phase 4)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Prediabetic State (Phase 4)

Prostatic Neoplasms (Phase 2)

Rectal Neoplasms (Phase 4)

Tendinopathy (Phase 4)

Waldenstrom Macroglobulinemia (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 27
  • # of Trial APIs: 35